Latest
Bosulif Approved for Pediatric Patients With Chronic Phase Ph+ CML
Postoperative Complications Common After Spinal Surgery for Multiple Myeloma
Proteinuria Higher With Dasatinib Exposure in Chronic Myelogenous Leukemia
Limited Efficacy Seen With Ixazomib Plus Daratumumab and Low-Dose Dexamethasone in Intermediate-Fit Patients With MM
Allo-HSCT May Be Beneficial in Patients With Relapsed/Refractory AML
State Policies May Prevent Cancer Patients From Using Telehealth
High-Dose Chemo and HSCT Linked to Second Primary Malignancies in Lymphoma Survivors
Risk for Intracerebral Hemorrhage May Be Transmissible Via Blood Transfusion
Abatacept Trough Level After Dose 1 Associated With Risk of Acute GVHD
Genome-Edited Product May Attenuate Sickle Cell Disease
Implicit Bias, Healthcare Inequities Impact Cancer Care for Patients with Disabilities
Fluticasone Furoate Does Not Cut Time to COVID-19 Symptom Resolution
Featured Content
A New Era in Awareness for Sickle Cell Disease Testing in the Caribbean
Researchers in the Caribbean are seeking to make strides in care and testing for patients with sickle cell disease.
Managing Acute Vaso-Occlusive Crises in Sickle Cell Disease
Researchers have sought to determine better ways to manage patients with SCD experiencing pain or a vaso-occlusive sickle cell crisis.
Cost and Allocation of Scarce CAR-T Therapy for Patients With Multiple Myeloma
Researchers sought to determine the allocation and cost involved with CAR-T therapy for patients with multiple myeloma.
With Twitter (Now X) in Flux, Is #MedTwitter Under Threat?
Oncology professionals share what #MedTwitter means to them and where they might go if Twitter (now X) becomes obsolete.
- Loading...
Loading...
Loading... 
Loading...